Legal Woes Drive Illumina s Q2 Net Loss to $16M as Revenue Sees Strong Growth | GenomeWeb

NEW YORK, July 19 - Illumina reported today a significant increase in second-quarter revenues atop a widened net loss brought on after the company was forced to pay $7.7 million in legal damages for wrongfully firing co-founder and former chief scientific officer Anthony Czarnik.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.